Sandra Aguayo Castanon, P. A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 308 S Cesar Chavez Ave, Crystal City, TX 78839 Phone: 830-374-2301 Fax: 830-374-9368 |
Kiesha Sherree Wright, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 308 S Cesar Chavez Ave, Crystal City, TX 78839 Phone: 830-374-2301 Fax: 830-374-9368 |
Shirley Koehler, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 210 S Avenue C, Crystal City, TX 78839 Phone: 830-374-2952 Fax: 830-374-3784 |
Steven Paul Garza, P.A. Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 308 S Cesar Chavez Ave, Crystal City, TX 78839 Phone: 830-374-2301 Fax: 830-374-9368 |
News Archive
The severe impact of this infection has given rise to a study by Theiler et al. (2021), which investigated the effects of SARS-CoV-2 vaccination in pregnancy in order to examine the protection it could provide to combat the infection.
A study conducted at the Montreal Heart Institute (MHI) has shown unexpectedly that living with children is linked to a reduction in physical activity. Carried out with 756 participants and led by Dr. Simon L. Bacon, Associate Researcher at the MHI and Professor at Concordia University, the study assessed the impact of social networks on exercise, revealing that people with heart disease who live with children exercise less than those people who do not live with children.
StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.
› Verified 5 days ago